Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berneman

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Archives of Dermatological Research|May 25, 2002
Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysisAnn C A De Smedt, Rosette L Van Den Heuvel, Vigor F I Van Tendeloo, et al.
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Leukemia|May 1, 1988
Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemiaZ N Berneman, D R van Bockstaele, M Van den Bergh, et al.
Plos One|May 8, 2015
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent MannerSébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, et al.
Frontiers in Immunology|August 6, 2019
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation AntigenMarijke Timmers, Gils Roex, Yuedi Wang, et al.
Journal of Clinical Medicine|May 1, 2019
Dendritic Cell-Based Immunotherapy of Acute Myeloid LeukemiaHeleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, et al.
Mediators of Inflammation|November 26, 2015
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple SclerosisNathalie Deckx, Inez Wens, Amber H Nuyts, et al.
Cytotherapy|June 17, 2009
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trialAnn Van Driessche, Ann L R Van de Velde, Griet Nijs, et al.
Pharmacological Reviews|August 5, 2015
Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapySébastien Anguille, Evelien L Smits, Christian Bryant, et al.
Blood|April 26, 2000
Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alphaS F Weekx, H W Snoeck, F Offner, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Archives of Dermatological Research|May 25, 2002
Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysisAnn C A De Smedt, Rosette L Van Den Heuvel, Vigor F I Van Tendeloo, et al.
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Leukemia|May 1, 1988
Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemiaZ N Berneman, D R van Bockstaele, M Van den Bergh, et al.
Plos One|May 8, 2015
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent MannerSébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, et al.
Frontiers in Immunology|August 6, 2019
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation AntigenMarijke Timmers, Gils Roex, Yuedi Wang, et al.
Journal of Clinical Medicine|May 1, 2019
Dendritic Cell-Based Immunotherapy of Acute Myeloid LeukemiaHeleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, et al.
Mediators of Inflammation|November 26, 2015
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple SclerosisNathalie Deckx, Inez Wens, Amber H Nuyts, et al.
Cytotherapy|June 17, 2009
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trialAnn Van Driessche, Ann L R Van de Velde, Griet Nijs, et al.
Pharmacological Reviews|August 5, 2015
Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapySébastien Anguille, Evelien L Smits, Christian Bryant, et al.
Blood|April 26, 2000
Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alphaS F Weekx, H W Snoeck, F Offner, et al.
Pageof 22